Antimalarial drug discovery: efficacy models for compound screening
Top Cited Papers
- 1 June 2004
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 3 (6) , 509-520
- https://doi.org/10.1038/nrd1416
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- The Transcriptome of the Intraerythrocytic Developmental Cycle of Plasmodium falciparumPLoS Biology, 2003
- Artemisinins target the SERCA of Plasmodium falciparumNature, 2003
- The Common Technical Document: the changing face of the New Drug ApplicationNature Reviews Drug Discovery, 2003
- Genome sequence of the human malaria parasite Plasmodium falciparumNature, 2002
- Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometryNature, 2002
- A proteomic view of the Plasmodium falciparum life cycleNature, 2002
- Chloroquine‐Resistant MalariaThe Journal of Infectious Diseases, 2001
- Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial DrugsScience, 1999
- The effect of combinations of qinghaosu (artemisinin) with standard antimalarial drugs in the suppressive treatment of malaria in miceTransactions of the Royal Society of Tropical Medicine and Hygiene, 1987
- The production of mature gametocytes of Plasmodium falciparum in continuous cultures of different isolates infective to mosquitoesTransactions of the Royal Society of Tropical Medicine and Hygiene, 1982